Target intelligence / Profile preview

RNF32 antisense RNA 1 (RNF32-AS1)

Target
RNF32-AS1
Molecular classification
Other, Antisense RNA, Long noncoding RNA (lncRNA)
01

Overview

**RNF32 antisense RNA 1 (RNF32-AS1)** is a long noncoding RNA (lncRNA) transcribed from the opposite DNA strand of the RNF32 gene locus[1]. Antisense RNAs, such as RNF32-AS1, often function in the regulation of gene expression, either by interacting with the sense transcript of the gene from which they are derived or by modifying chromatin and transcriptional activity at the locus[4]. The specific functional, biological, and clinical roles of RNF32-AS1 remain poorly characterized, with no evidence as of the available search results for direct involvement in human disease, no reported interactions with drugs, and no defined mechanism of action as a therapeutic target. General roles for antisense RNAs include cis- or trans-regulation of gene expression, and they may influence molecular processes such as transcriptional interference or epigenetic modification[4]. There is no evidence in the current biomedical literature that RNF32-AS1 is an established therapeutic target or clinically utilized biomarker[1].

Other names
RNF32-AS1RNF32 Antisense RNA 1
02

Biological functions

Regulation of gene expressionPotential regulation in cis or trans of nearby gene RNF32Possible involvement in transcriptional interference or chromatin modification, based on general antisense RNA function
03

Disease associations

Other (no specific, direct disease association reported for RNF32-AS1 as of this search)

Beyond the preview

Go deeper on RNF32 antisense RNA 1 (RNF32-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNF32 antisense RNA 1 (RNF32-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call